Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
64,326,281
-
Total 13F shares
-
52,988,211
-
Share change
-
+1,720,488
-
Total reported value
-
$1,917,110,562
-
Put/Call ratio
-
216%
-
Price per share
-
$36.18
-
Number of holders
-
169
-
Value change
-
+$57,678,654
-
Number of buys
-
102
-
Number of sells
-
78
Institutional Holders of Vera Therapeutics, Inc. - COMMON STOCK (VERA) as of Q2 2024
As of 30 Jun 2024,
Vera Therapeutics, Inc. - COMMON STOCK (VERA) was held by
169 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,988,211 shares.
The largest 10 holders included
Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., FMR LLC, Sofinnova Investments, Inc., VANGUARD GROUP INC, COMMODORE CAPITAL LP, STATE STREET CORP, Eversept Partners, LP, and Holocene Advisors, LP.
This page lists
169
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.